NEW YORK (GenomeWeb News) – Protein Discovery and New Objective will co-market each other's proteomics technologies and will develop new products under a new agreement, Protein Discovery said today.

The marketing agreement covers Protein Discovery's GelFree 8100 Fractionation System and New Objectives' PicoFrit nanobore chromatography columns and Digital PicoView nanospray sources.

Protein Discovery said that the combined technologies will give researchers top-down protein analysis with an integrated, standardized workflow for mass spectrometry projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.